Implementing pharmacy practice research programs for the management of heart failure.
It stands to reason that pharmacists would have a beneficial role in the treatment of patients with chronic illnesses wherein complicated pharmacotherapies are required to reduce the risk of acute exacerbation. For chronic heart failure, recent evidence bears this out. When pharmacists take time to provide self-care instructions for patients with heart failure or take part in collaborative healthcare teams, the need for costly urgent healthcare decreases with corresponding decreases in healthcare costs. Further research is needed to address the key supportive roles of pharmacists in the treatment of patients with heart failure.
Murray
Michael D
MD
Purdue University College of Pharmacy, West Lafayette, IN 47907, USA. mmurray@regenstrief.org
D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D054539:Medication Therapy Management / Q000191:economics / Q000458:organization & administration*; D017063:Outcome Assessment, Health Care; D010348:Patient Care Team / Q000191:economics / Q000458:organization & administration*; D010353:Patient Education as Topic / Q000191:economics / Q000458:organization & administration*; D010593:Pharmaceutical Services / Q000191:economics / Q000458:organization & administration; D010595:Pharmacists
D002317:Cardiovascular Agents